Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
accepted calculation method

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1980
Report date:
1980

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Standardised study (BASF test) to determine the acute toxicity of the test item in male and female mice after single i.p. application (observation period: 14 days).
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
N-ethylpropylamine
EC Number:
243-573-4
EC Name:
N-ethylpropylamine
Cas Number:
20193-20-8
Molecular formula:
C5H13N
IUPAC Name:
N-ethylpropan-1-amine
Details on test material:
- Name of test material (as cited in study report): Aethylpropylamin
- Physical state: liquid
- Analytical purity: 99 %

Test animals

Species:
mouse
Strain:
NMRI
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: WIGA
- Housing: Makrolon Typ II (max. 5 animals per cage)
- Diet: standard pellet feed for rats and mice ad libitum
- Water: ad libitum
- Acclimation period: 3 - 7 days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 - 23°C
- Humidity (%): 50 - 70%
- Photoperiod (hrs dark / hrs light): 12 / 12

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
other: 0.5% CMC (carboxymethyl cellulose) aqueous solution
Doses:
23.7, 34.8, 51.1, 75.0, 110, 162 mg/kg bw
No. of animals per sex per dose:
5 male animals (23.7 mg/kg bw); 5 male and 5 female animals (34.8, 51.1, 75.0, 110, 162 mg/kg bw)
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: daily
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight
Statistics:
Probit-analysis according to Finney

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
60.3 mg/kg bw
Based on:
test mat.
95% CL:
48.8 - 74.4
Remarks on result:
other: Mortality and several clinical signs observed.
Mortality:
23.7 mg/kg bw: no mortality observed.
38.4 mg/kg bw: 2 males died within 7 days.
51.1 mg/kg bw: 2 males and 1 female died within 7 days and a further male within 14 days.
75.0 mg/kg bw: 3 males and 3 females died within 7 days.
110 mg/kg bw: 1 female died within 24 h, 3 males within 48 h. 3 further females and 1 further male died within 7 days.
162 mg/kg bw: 4 males and 2 females died within 24 h, 1 further male and 1 further female died within 48 h, the last 2 females died within 7 and 14 days.
Clinical signs:
34.8 mg/kg onwards: apathy, ruffled fur, tight eyelids. After 12 days all animals were considered as normal.
Body weight:
All surviving animals gained normal weight.
Gross pathology:
dead animals: 30 dead animals, necropsy was not performed with 6 animals (autolysis and /or nibbled), 11 mice were without findings
110 mg/kg: Gastro-intestinal region filled with green-blackish content.
162 mg/kg: Intestine partially reddened, mesenteric vascular walls clearly visible. 1 animal with green-blackish filled gastro-intestinal region. A further animal had dark red left testis and epididymis.

sacrificed animals: No abnormalities.

Any other information on results incl. tables

Mortality:

 Dose (mg/kg) gender  dead within 1h  dead within 1 day  dead within 2 days  dead within 7 days  dead within 14 days  
23.7 male 0/5 0/5 0/5 0/5 0/5  
23.7 female - - - - -  
34.8 male 0/5 0/5 0/5 2/5 2/5  
34.8 female 0/5 0/5 0/5 0/0 0/5
51.1 male 0/5 0/5 0/5 2/5 3/5
51.1 female 0/5 0/5 0/5 1/5 1/5  
75.0 male 0/5 0/5  0/5   3/5 3/5   
75.0 female 0/5 0/5 0/5 3/5 3/5  
110 male 0/5  0/5 3/5   4/5 4/5   
110 female  0/5  1/5 1/5 4/5 4/5  
162 male  0/5  4/5 5/5 5/5 5/5  
162 female 0/5  2/5  3/5 4/5  5/5   

Applicant's summary and conclusion